The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Postprandial inflammation and endothelial dysfuction
Abstract
Postprandial hyperlipidaemia is a common metabolic disturbance in atherosclerosis. During the postprandial phase, chylomicrons and their remnants can penetrate the intact endothelium and cause foam cell formation. These particles are highly atherogenic after modification. People in the Western world are non-fasting for most of the day, which consequently leads to a continuous challenge of the endothelium by atherogenic lipoproteins and their remnants. Furthermore, atherosclerosis is considered a low-grade chronic inflammatory disease. Many studies have shown that the process of atherogenesis in part starts with the interaction between the activated leucocytes and activated endothelium. Postprandial lipoproteins can activate leucocytes in the blood and up-regulate the expression of leucocyte adhesion molecules on the endothelium, facilitating adhesion and migration of inflammatory cells into the subendothelial space. Another inflammatory process associated with postprandial lipaemia is the activation of the complement system. Its central component C3 has been associated with obesity, coronary sclerosis, the metabolic syndrome and fasting and postprandial TAGs (triacylglycerols). Moreover, chylomicrons are the strongest stimulators of adipocyte C3 production via activation of the alternative complement cascade. A postprandial C3 increment has been shown in healthy subjects and in patients with CAD (coronary artery disease) and with FCHL (familial combined hyperlipidaemia). Postprandial lipaemia has been related to TAG and free fatty acid metabolism. All of these mechanisms provide an alternative explanation for the atherogenicity of the postprandial period.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In obese non-diabetic or diabetic individuals, several studies have observed improvement of insulin sensitivity after prolonged treatment with neutralising TNF-a antibodies (150,151) , whereas other trials did not report such effects of TNF-a antibody injections, despite dampening of systemic inflammation (152) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [152]
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Atherogenesis: a postprandial phenomenon.
Zilversmit, D. B. (1979) · Circulation · doi:10.1161/01.cir.60.3.473 · Cited by 1,701
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Schmidt, M. I., Duncan, B. B., Sharrett, A. R., Lindberg, G., Savage, P. J., Offenbacher, S., Azambuja, M. I. R., Tracy, R. P., & HEISS, G. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01046-6 · Cited by 1,080
Diabetic dyslipidaemia: from basic research to clinical practice*
Taskinen, M.-R. (2003) · Diabetologia · doi:10.1007/s00125-003-1111-y · Cited by 888
Cholesteryl Ester Transfer Protein
Barter, P. J., Brewer, H. B., Chapman, M. J., Hennekens, C. H., Rader, D. J., & Tall, A. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000054658.91146.64 · Cited by 868
Flagged first, then by citations
Research works printed but not linked: 4
- Wanten, 2001, J. Lipid Res., 24, 228
- Skrede, 1992, Eur. J. Clin. Invest., 94, 19
- Alipour, 2006, Circulation, 114, 1741
- Lefebvre, 1998, Diabet. Met., 15, S63
Cited by
Sorted by citations
Items 101–108 of 108
Whey Protein and the Metabolic Syndrome
Pal, S., Jane, M., McKay, J., & Ho, S. S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813822-9.00007-2
Derosa, G., Raddino, R., Maggi, A., Pasini, G., D’Angelo, A., & Maffioli, P. (2020) · doi:10.12691/jfnr-8-4-4
“This model has been widely applied in a relatively small sample of subjects to study post-prandial lipidemia and to verify the effect it can have on inflammatory parameters, circulating markers of endothelial dysfunction, and prothrombotic variables [5,6].”
MethodThe Effects of ChondroT on Thrombus in FeCl3-induced Rats
Kim, J. H., Kim, S. G., Kim, J. I., Yoon, C. S., Choi, J. M., Na, C. S., & Kim, S. J. (2020) · Journal of Korean Medicine Rehabilitation · doi:10.18325/jkmr.2020.30.3.45
Derosa, G., Gaudio, G. V., D’Angelo, A., & Maffioli, P. (2020) · doi:10.12691/jfnr-8-12-2
“This model has been widely applied in a relatively small sample of subjects to study post-prandial lipidemia and to verify the effect it can have on some parameters and conditions [7,8].”
MethodAdhesion Molecules in Obesity and Metabolic Syndrome
Miller, M. A. (2010) · Science Publishers eBooks · doi:10.1201/b10167-14
(2016) · CRC Press eBooks · doi:10.1201/9780429196393-41
The “SMART” side of hypertriglyceridemia
Cabezas, M. C., & Klop, B. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120467
Systemic inflammation and ex vivo inflammatory responses in first semester university students
Davis, K. M., Wright, M. A., Engeland, C. G., & Murdock, K. W. (2025) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2025.107729
Metadata
- Authors
- Alipour, A., Elte, J. W. F., van Zaanen, H. C. T., Rietveld, A. P., & Cabezas, M. C.
- Affiliations
- Sint Franciscus Gasthuis (NL)
- Department of Internal Medicine, St Franciscus Gasthuis, Center for Diabetes and Vascular Medicine, PO Box 10900, 3004 BA Rotterdam, The Netherlands
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-05-22
- Volume
- 35
- Issue
- 3
- Pages
- 466-469
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2102556811
- Cited by
- 108
- References
- 47
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 1 · 2021: 3 · 2020: 4 · 2019: 7 · 2018: 4 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 11 · 2013: 6 · 2012: 4
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemical Society Transactions (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- endothelial dysfunction, postprandial inflammation, atherosclerosis, chylomicrons, chylomicron remnants, foam cell formation, complement C3, alternative complement pathway, adipocytes, leukocyte activation, coronary artery disease, familial combined hyperlipidaemia, triglycerides, free fatty acids, low-grade inflammation
- MeSH terms
- Animals, Chylomicrons, Complement C3, Endothelium, Vascular, Humans, Hyperlipidemias, Inflammation, Models, Cardiovascular, Postprandial Period, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
